Breaking News Instant updates and real-time market news.

2020-11-24 09:23:15 ENTA Enanta $43.78 / +0.18 (+0.41%) , ABBV AbbVie $102.20 / +1.33 (+1.32%) 09:23 11/24/20 11/24 09:23 11/24/20 09:23	Enanta price target lowered to $45 from $52 at RBC Capital RBC Capital analyst Brian Abrahams lowered the firm's price target on Enanta (ENTA) to $45 from $52 and keeps a Sector Perform rating on the shares after its Q4 earnings miss. The analyst also notes that the Hepatitis-C virus royalties from partner AbbVie (ABBV) were generally in line with expectations, and the company's pipeline is "continuing to move along." Abrahams adds that Enanta's "strong" balance sheet should continue to fund its "solid" R&D engine, though he continues to see challenges to the programs that the company is pursuing. ENTA Enanta $43.78 / +0.18 (+0.41%) ABBV AbbVie $102.20 / +1.33 (+1.32%)	04 Dec 31 Mar
ENTA ABBV ENTA Enanta $43.78 / +0.18 (+0.41%) 11/24/20 Evercore ISI Evercore cautious on Enanta into 2021, starts with Underperform 11/23/20 Evercore ISI Enanta initiated with an Underperform at Evercore ISI 10/26/20 Roth Capital Enanta price target raised to $107 from $104 at Roth Capital 08/28/20 Fly Intel: Top five analyst initiations ABBV AbbVie $102.20 / +1.33 (+1.32%) 11/18/20 Fly Intel: Top five analyst initiations 11/18/20 BMO Capital AbbVie initiated with an Outperform at BMO Capital 11/12/20 Canaccord Neurocrine price target lowered to $122 from $145 at Canaccord 11/11/20 JPMorgan AbbVie valuation remains 'very attractive,' says JPMorgan

2020-11-24 09:23:15

ENTA

Enanta

$43.78 / +0.18 (+0.41%)

, ABBV

AbbVie

$102.20 / +1.33 (+1.32%)

09:23

11/24/20

11/24

09:23

11/24/20

09:23

Enanta price target lowered to $45 from $52 at RBC Capital

RBC Capital analyst Brian Abrahams lowered the firm's price target on Enanta (ENTA) to $45 from $52 and keeps a Sector Perform rating on the shares after its Q4 earnings miss. The analyst also notes that the Hepatitis-C virus royalties from partner AbbVie (ABBV) were generally in line with expectations, and the company's pipeline is "continuing to move along." Abrahams adds that Enanta's "strong" balance sheet should continue to fund its "solid" R&D engine, though he continues to see challenges to the programs that the company is pursuing.

ENTA

Enanta

$43.78 / +0.18 (+0.41%)

ABBV

AbbVie

$102.20 / +1.33 (+1.32%)

04
Dec
31
Mar

ENTA
ABBV

ENTA Enanta

$43.78 / +0.18 (+0.41%)

11/24/20 Evercore ISI: Evercore cautious on Enanta into 2021, starts with Underperform

11/23/20 Evercore ISI: Enanta initiated with an Underperform at Evercore ISI

10/26/20 Roth Capital: Enanta price target raised to $107 from $104 at Roth Capital

08/28/20: Fly Intel: Top five analyst initiations

ABBV AbbVie

$102.20 / +1.33 (+1.32%)

11/18/20: Fly Intel: Top five analyst initiations

11/18/20 BMO Capital: AbbVie initiated with an Outperform at BMO Capital

11/12/20 Canaccord: Neurocrine price target lowered to $122 from $145 at Canaccord

11/11/20 JPMorgan: AbbVie valuation remains 'very attractive,' says JPMorgan

TODAY'S FREE FLY STORIES

Recommendations	KBC Group price target lowered to EUR 60 from EUR 61 at Deutsche Bank » 11:27 01/20/21 01/20 11:27 01/20/21 11:27 KBCSY KBC Group $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KBCSY KBC Group $0.00 / + (+0.00%) 01/14/21 Morgan Stanley KBC Group price target raised to EUR 71 from EUR 67 at Morgan Stanley 01/11/21 Deutsche Bank KBC Group downgraded to Hold from Buy at Deutsche Bank 01/07/21 Credit Suisse KBC Group downgraded to Neutral from Outperform at Credit Suisse 01/07/21 Credit Suisse KBC Group downgraded to Neutral from Outperform at Credit Suisse
Recommendations	Carl Zeiss Meditec price target raised to EUR 140 from EUR 120 at Deutsche Bank » 11:26 01/20/21 01/20 11:26 01/20/21 11:26 CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 10/07/20 Microsoft, Zeiss announce multi-year strategic partnership CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 11/02/20 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 120 from EUR 110 at Deutsche Bank 10/23/20 UBS Carl Zeiss Meditec downgraded to Neutral from Buy at UBS 07/17/20 Berenberg Carl Zeiss Meditec price target raised to EUR 87 from EUR 81 at Berenberg 07/16/20 Deutsche Bank Carl Zeiss Meditec price target lowered to EUR 110 at Deutsche Bank
Recommendations	AirBoss of America price target lowered to C$28 from C$31 at CIBC » 11:20 01/20/21 01/20 11:20 01/20/21 11:20 ABSSF AirBoss of America $0.00 / + (+0.00%) CIBC analyst Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ABSSF AirBoss of America $0.00 / + (+0.00%) 10/26/20 AirBoss of America acquires 100% ownership of Airboss Defense Group 10/05/20 AirBoss of America announces $22M in awards across ADG's survivability portfolio 09/28/20 AirBoss of America announces Husky long-term contract extension ABSSF AirBoss of America $0.00 / + (+0.00%) 01/14/21 Canaccord AirBoss of America price target lowered to C$27 from C$43 at Canaccord 12/18/20 TD Securities AirBoss of America price target lowered to C$29 from C$32 at TD Securities 11/12/20 Stifel AirBoss of America price target lowered to C$33 from C$34 at Stifel 11/12/20 TD Securities AirBoss of America price target raised to C$32 from C$31 at TD Securities ABSSF AirBoss of America $0.00 / + (+0.00%) 01/19/21 AirBoss of America sees 2020 revenue $498M-$503M
Options	Vertical call spread in energy ETF targets 26% return for 2021 » 11:20 01/20/21 01/20 11:20 01/20/21 11:20 XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) Vertical call spread in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Options Technical Analysis XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 12/29/20 Alpha One Capital's Dan Niles likes JPMorgan, Oracle, Magna Intl, Gan Ltd in '21 08/05/20 Energy shares surge amid spike in natural gas, crude inventory drop XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 07/06/20 Goldman Sachs Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 01/08/21 Size call sale in Energy ETF likely closes December trade 12/14/20 Unusually active option classes on open December 14th XLE Energy Select Sector SPDR $43.50 / -0.12 (-0.28%) 08:25 Today Energy Select Sector SPDR: Pivot points 01/15/21 On The Fly: Weekly technical notes for S&P 500 01/15/21 Energy Select Sector SPDR: Pivot points 01/14/21 Energy Select Sector SPDR: Pivot points
Periodicals	Brookfield, KKR mull offers for $10B Aramco pipeline stake, Bloomberg says » 11:18 01/20/21 01/20 11:18 01/20/21 11:18 BAM Brookfield $38.51 / +0.18 (+0.47%) , KKR KKR $41.52 / +0.55 (+1.34%) , APO Apollo Global $48.08 / -0.1 (-0.21%) Brookfield Asset… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 01/04/21 Brookfield Property establishes committee to review Brookfield proposal 01/04/21 Brookfield proposes to acquire remaining Brookfield Property units for $5.9B 12/30/20 JCPenney replacing CEO Jill Soltau, Stanley Shashoua stepping in for now 12/14/20 Blackstone unit BPPLS to acquire portfolio of lab properties for $3.45B KKR KKR $41.52 / +0.55 (+1.34%) 01/13/21 KKR closes first Asia real estate Fund at $1.7B 01/13/21 Fiserv, KKR called out as best ideas by Oakmark's Bill Nygren 01/12/21 KKR expands real estate industrial portfolio in Phoenix 01/11/21 KKR invests in music catalog of Ryan Tedder and OneRepublic APO Apollo Global $48.08 / -0.1 (-0.21%) 01/04/21 Takkion Holdings acquires Renew Energy; terms not disclosed 12/23/20 Apollo-led group to acquire 49.9% stake in AB InBev U.S. metal container plants 12/21/20 Apollo agrees to increase Great Canadian Gaming purchase price to C$45 per share 12/15/20 Cardtronics transaction indicates enterprise value of $2.3B, including net debt BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 01/05/21 JPMorgan Brookfield deal 'value accretive and multiple enhancing,' says JPMorgan 12/23/20 RBC Capital Brookfield assumed with an Outperform at RBC Capital 11/18/20 Fly Intel: Top five analyst initiations 11/18/20 Goldman Sachs Brookfield initiated with a Conviction Buy at Goldman Sachs KKR KKR $41.52 / +0.55 (+1.34%) 01/11/21 Citi Citi opens 'positive Catalyst Watches' on Invesco, Carlyle, KKR 11/11/20 Deutsche Bank KKR price target raised to $40 from $38 at Deutsche Bank 08/05/20 Citi Citi adds KKR to U.S. Focus List, ups price target to $47.50 07/09/20 Keefe Bruyette KKR price target raised to $41 from $34 at Keefe Bruyette APO Apollo Global $48.08 / -0.1 (-0.21%) 09:15 Today Truist Athene Holding price target raised to $55 from $48 at Truist 01/11/21 Wells Fargo Apollo Global price target raised to $55 from $50 at Wells Fargo 12/18/20 Deutsche Bank Apollo Global price target raised to $51 from $49 at Deutsche Bank 11/06/20 Fly Intel: Top five analyst upgrades BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 11/12/20 Brookfield reports Q3 EPS 10c, consensus 47c 08/13/20 Brookfield reports Q2 EPS (43c), consensus 39c KKR KKR $41.52 / +0.55 (+1.34%) 10/30/20 KKR reports Q3 EPS 48c, consensus 40c 08/04/20 KKR reports Q2 adjusted EPS 39c, consensus 36c 08/03/20 Notable companies reporting before tomorrow's open 08/03/20 Notable companies reporting before tomorrow's open APO Apollo Global $48.08 / -0.1 (-0.21%) 10/29/20 Apollo Global reports Q3 fee-related EPS 63c, consensus 49c 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 07/30/20 Apollo Global reports Q2 fee-related EPS 59c, consensus 48c 11 Nov BAM KKR APO BAM Brookfield $38.51 / +0.18 (+0.47%) 11/10/20 Brookfield seeks to enter secondary market for private assets, Bloomberg says 10/25/20 Blackstone to buy Simply Self storage for $1.2B, WSJ reports 10/22/20 JCPenney's new owners reject pension plan, Dallas Morning News reports 10/19/20 Brookfield investing $2B in biggest Indian property deal yet, Bloomberg says KKR KKR $41.52 / +0.55 (+1.34%) 01/13/21 KKR closes inaugural APAC real estate fund at $1.7B, Reuters says 11/19/20 Bain, KKR weigh offers for Hitachi Metals, Nikkei Asia reports 11/18/20 Epic, Spotify not impressed with Apple App Store policy update, CNBC says 11/05/20 'Fortnite' to be playable on iOS devices via Nvidia GeForce, BBC reports APO Apollo Global $48.08 / -0.1 (-0.21%) 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 01/08/21 NCR in talks to bid against Apollo for Cardtronics, WSJ reports 12/11/20 Apollo, Blackstone in talks for Wells Fargo student loan book, Bloomberg says 12/11/20 Apollo, Blackstone in talks for Wells Fargo student loan book, Bloomberg says APO APO Apollo Global $48.08 / -0.1 (-0.21%) 09/25/20 Sports betting space gains after William Hill receives two takeover offers 09/25/20 Fly Intel: Pre-market Movers 09/24/20 SPACs under pressure as SEC chairman voices disclosure concerns 09/03/20 Tesla slides as investor trims stake, QuantumScape joins EV SPAC craze 02/24/21 22nd Annual Virtual Financial Services Forum 02/03/21 Apollo Global - APO 02/11/21 Brookfield - BAM APO APO Apollo Global $48.08 / -0.1 (-0.21%) 10/22/20 Apollo Global put volume heavy and directionally bearish

Syndicate	Oyster Enterprises Acquisition opens at $10.17, IPO priced at $10 per unit » 11:18 01/20/21 01/20 11:18 01/20/21 11:18 OSTR Oyster Enterprises Acquisition $0.00 / + (+0.00%) Oyster Enterprises… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Technical Analysis	NASDAQ market internals summary » 11:17 01/20/21 01/20 11:17 01/20/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary 01/19/21 NASDAQ market internals summary
Recommendations	Travis Perkins price target raised to 1,450 GBp from 1,360 GBp at Canaccord » 11:15 01/20/21 01/20 11:15 01/20/21 11:15 TVPKF Travis Perkins $0.00 / + (+0.00%) Canaccord analyst Aynsley… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research TVPKF Travis Perkins $0.00 / + (+0.00%) 01/08/21 JPMorgan Travis Perkins upgraded to Neutral from Underweight at JPMorgan 12/18/20 RBC Capital Travis Perkins price target raised to 1,300 GBp from 1,250 GBp at RBC Capital 04/08/20 JPMorgan Travis Perkins downgraded to Underweight from Neutral at JPMorgan
General news	FX Action: USD-CAD » 11:15 01/20/21 01/20 11:15 01/20/21 11:15 FX Action: USD-CAD… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Vermilion Energy price target raised to C$8 from C$7 at RBC Capital » 11:11 01/20/21 01/20 11:11 01/20/21 11:11 VET Vermilion Energy $5.80 / +0.28 (+5.07%) RBC Capital analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VET Vermilion Energy $5.80 / +0.28 (+5.07%) 11/17/20 Vermilion Energy announces changes to its leadership team 09/24/20 Vermilion Energy provides update on Total's Grandpuits refinery conversion VET Vermilion Energy $5.80 / +0.28 (+5.07%) 01/19/21 National Bank Vermilion Energy price target lowered to C$6.50 from C$7 at National Bank 01/19/21 TD Securities Vermilion Energy price target lowered to C$6.50 from C$7 at TD Securities 01/15/21 Raymond James Vermilion Energy upgraded to Outperform from Market Perform at Raymond James 01/14/21 Scotiabank Vermilion Energy price target raised to C$8.50 from C$8 at Scotiabank VET Vermilion Energy $5.80 / +0.28 (+5.07%) 11/09/20 Vermilion Energy reports Q3 FFO 73c vs. $1.39 last year 07/27/20 Vermilion Energy reports Q2 FFO 52c vs. $1.09 last year

Options	Bull tries on $2M worth of Under Armour March 20 calls » 11:10 01/20/21 01/20 11:10 01/20/21 11:10 UAA Under Armour $18.45 / +0.325 (+1.79%) Bull tries on $2M worth… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options UAA Under Armour $18.45 / +0.325 (+1.79%) 12/04/20 Virgin Galactic unveils spacesuits developed in partnership with Under Armour 12/01/20 Under Armour announces creation and launch of Curry Brand 10/30/20 Under Armour says has line of sight to deliver slightly positive EPS in 2021 10/30/20 Under Armour to sell MyFitnessPal platform to Francisco Partners in $345M deal UAA Under Armour $18.45 / +0.325 (+1.79%) 01/15/21 B. Riley Securities Under Armour price target raised to $15 from $13 at B. Riley Securities 01/07/21 JPMorgan Under Armour price target raised to $19 from $17 at JPMorgan 01/04/21 Pivotal Research Under Armour upgraded to Buy from Hold at Pivotal Research 12/09/20 UBS Under Armour price target raised to $17 from $10 at UBS UAA Under Armour $18.45 / +0.325 (+1.79%) 10/30/20 Under Armour sees FY20 adj. EPS (49c)-(47c), consensus (72c) 10/30/20 Under Armour sees Q4 revenue down low-teen percentage rate, consensus $1.12B 10/30/20 Under Armour reports Q3 adj. EPS 26c, consensus 3c 10/29/20 Notable companies reporting before tomorrow's open UAA Under Armour $18.45 / +0.325 (+1.79%) 12/14/20 Under Armour sued over 'infrared' claims about workout wear, Bloomberg reports 12/01/20 Under Armour, NBA's Steph Curry to launch 'Curry Brand,' NY Post reports 10/22/20 Short-seller GlassHouse Research sees 51% downside for Columbia Sportswear 08/27/20 Under Armour sued by UCLA for pulling out of apparel deal, LA Times reports UAA Under Armour $18.45 / +0.325 (+1.79%) 10/30/20 Fly Intel: Pre-market Movers 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 07/31/20 Fly Intel: Pre-market Movers 07/27/20 Fly Intel: Pre-market Movers UAA Under Armour $18.45 / +0.325 (+1.79%) 12/08/20 Unusual call flow in option market yesterday 12/07/20 Upside call buyer in Under Armour closing position 12/07/20 Unusually active option classes on open December 7th 10/30/20 Unusually active option classes on open October 30th
Recommendations	Capstone Mining price target raised to C$3 from C$2.60 at BMO Capital » 11:09 01/20/21 01/20 11:09 01/20/21 11:09 CSFFF Capstone Mining $0.00 / + (+0.00%) BMO Capital analyst Rene… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 11:00 Today TD Securities Capstone Mining price target raised to C$3.50 from C$3 at TD Securities 01/11/21 Scotiabank Capstone Mining price target raised to C$4 from C$3 at Scotiabank 01/08/21 Canaccord Capstone Mining price target raised to C$3.50 from C$3 at Canaccord 01/06/21 National Bank Capstone Mining price target raised to C$3.25 from C$2.10 at National Bank
On The Fly	Netflix subscriber growth, buyback potential wins over two new bulls » 11:07 01/20/21 01/20 11:07 01/20/21 11:07 NFLX Netflix $571.28 / +69.24 (+13.79%) Shares of Netflix (NFLX)… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $571.28 / +69.24 (+13.79%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $571.28 / +69.24 (+13.79%) 09:56 Today Fly Intel: Top five analyst upgrades 09:18 Today JPMorgan Netflix price target raised to $685 from $628 at JPMorgan 09:04 Today Morgan Stanley Netflix price target raised to $700 from $650 at Morgan Stanley 09:00 Today Wedbush Netflix price target raised to $340 from $235 at Wedbush NFLX Netflix $571.28 / +69.24 (+13.79%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $571.28 / +69.24 (+13.79%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $571.28 / +69.24 (+13.79%) 08:59 Today Fly Intel: Pre-market Movers 01/19/21 Fly Intel: After-Hours Movers 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 12/09/20 Disney rises as Wall Street analysts get more bullish ahead of investor day NFLX Netflix $571.28 / +69.24 (+13.79%) 09:55 Today Early notable gainers among liquid option names on January 20th 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th
Recommendations	Theratechnologies price target lowered to C$3.75 from C$4 at National Bank » 11:06 01/20/21 01/20 11:06 01/20/21 11:06 THTX Theratechnologies $2.26 / -0.005 (-0.22%) National Bank lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings THTX Theratechnologies $2.26 / -0.005 (-0.22%) 01/07/21 Theratechnologies gets Study May Proceed letters for tesamorelin, TH1902 trials 12/08/20 Theratechnologies announces preclinical in vivo findings for TH1902 11/16/20 Theratechnologies announces data from oral presentation at AASLD 11/03/20 Theratechnologies announces departure of Chief Commercial Officer Antunovic THTX Theratechnologies $2.26 / -0.005 (-0.22%) 01/07/21 Theratechnologies sees 2020 revenue $65.8M-$66.1M vs. $63.2M last year 01/07/21 Theratechnologies sees Q4 revenue $18.9M-$19.2M vs. $16.4M last year 10/15/20 Theratechnologies reports Q3 EPS (9c) vs. (2c) last year 09/21/20 Theratechnologies sees Q3 revenue $13.8M-$14.2M vs. 16.1M last year
Recommendations	CanWel Building price target raised to C$8.50 from C$7.50 at National Bank » 11:06 01/20/21 01/20 11:06 01/20/21 11:06 CWXZF CanWel Building Materials $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CWXZF CanWel Building Materials $0.00 / + (+0.00%) 01/04/21 Raymond James CanWel Building Materials price target raised to C$9 at Raymond James 12/18/20 CIBC CanWel Building Materials price target raised to C$8.25 from C$8 at CIBC 12/16/20 National Bank CanWel price target lowered to C$7.50 from C$8 at National Bank 11/10/20 CIBC CanWel Building Materials price target raised to C$8 from C$7 at CIBC

Upgrade	Healthpeak upgraded to Overweight from Equalweight at Capital One » 11:05 01/20/21 01/20 11:05 01/20/21 11:05 PEAK Healthpeak $29.67 / +0.52 (+1.78%) Capital One analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events PEAK Healthpeak $29.67 / +0.52 (+1.78%) 01/05/21 Baird Healthpeak assumed with an Outperform at Baird 12/29/20 Barclays Healthpeak price target raised to $33 from $30 at Barclays 12/15/20 Citi Healthpeak price target raised to $30 from $28 at Citi 12/14/20 KeyBanc Healthpeak downgraded to Sector Weight from Overweight at KeyBanc PEAK Healthpeak $29.67 / +0.52 (+1.78%) 11/02/20 Healthpeak reports Q3 AFFO 40c, consensus 39c 08/04/20 Healthpeak reports Q2 AFFO 40c, consensus 40c 02/10/21 Healthpeak - PEAK
Options	First Majestic Silver call volume above normal and directionally bullish » 11:05 01/20/21 01/20 11:05 01/20/21 11:05 AG First Majestic $13.36 / +0.7 (+5.53%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options AG First Majestic $13.36 / +0.7 (+5.53%) 07:23 Today First Majestic plans to invest $168.4M on capital expenditures in 2021 07:22 Today First Majestic budgets $42.1M to be invested at Ermitano in 2021 07:20 Today First Majestic sees 2021 total production 20.6M-22.9M silver equivalent ounces 07:18 Today First Majestic reports 2020 silver production of 11.6M ounces AG First Majestic $13.36 / +0.7 (+5.53%) 01/11/21 National Bank First Majestic price target raised to C$20 from C$18 at National Bank 10/22/20 National Bank First Majestic price target lowered to C$18 from C$20 at National Bank 10/20/20 TD Securities First Majestic upgraded to Buy from Hold at TD Securities 09/11/20 National Bank First Majestic price target raised to C$20 from C$19 at National Bank AG First Majestic $13.36 / +0.7 (+5.53%) 11/05/20 First Majestic reports Q3 adj. EPS 12c, two est. (2c) 03/15/21 33rd Annual Roth Virtual Conference 10:00 Today First Majestic - AG AG First Majestic $13.36 / +0.7 (+5.53%) 01/19/21 First Majestic Silver call volume above normal and directionally bullish 12/21/20 First Majestic Silver call volume above normal and directionally bullish 12/16/20 First Majestic Silver call volume above normal and directionally bullish 12/15/20 First Majestic Silver call volume above normal and directionally bullish
Recommendations	Pan American Silver price target lowered to C$56 from C$60 at National Bank » 11:04 01/20/21 01/20 11:04 01/20/21 11:04 PAAS Pan American Silver $31.01 / +1.49 (+5.05%) National Bank analyst Don… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 01/19/21 Pan American Silver sees FY21 silver production up 35% from last year 11/04/20 Pan American Silver reports Q3 EPS 31c, consensus 38c 09/30/20 Pan American Silver restarts Huaron, Morococha operations in Peru 08/05/20 Pan American Silver reports mineral reserves estimate of 550M ounces of silver PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 07:43 Today Deutsche Bank Pan American Silver price target lowered to $26 from $35 at Deutsche Bank 01/13/21 Deutsche Bank Pan American Silver downgraded to Hold from Buy at Deutsche Bank 01/13/21 Deutsche Bank Pan American Silver downgraded to Hold from Buy at Deutsche Bank 01/11/21 National Bank Pan American Silver price target raised to C$60 from C$57 at National Bank PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 11/04/20 Pan American Silver reports Q3 adj. EPS 34c, consensus 38c 08/05/20 Pan American Silver reports Q2 adjusted EPS 28c, consensus 6c 02/18/21 Pan American Silver - PAAS PAAS Pan American Silver $31.01 / +1.49 (+5.05%) 12/11/20 Pan American Silver put volume heavy and directionally bearish 10/08/20 Pan American Silver put volume heavy and directionally bearish 08/11/20 Unusually active option classes on open August 11th 08/05/20 Pan American Silver call volume above normal and directionally bullish
Recommendations	Fortuna Silver Mines price target lowered to C$13 from C$14 at National Bank » 11:03 01/20/21 01/20 11:03 01/20/21 11:03 FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/19/21 Fortuna Silver Mines sees FY21 gold production 178,000-202,000 ounces 01/19/21 Fortuna Silver Mines reports FY20 silver production of 7.13M ounces, up 19% 12/01/20 Fortuna Silver Mines provides update on disputed royalty at San Jose Mine 10/20/20 Fortuna Silver Mines announces first gold pour at Lindero mine FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/11/21 National Bank Fortuna Silver Mines price target raised to C$14 from C$11 at National Bank 11/16/20 Canaccord Fortuna Silver Mines downgraded to Hold from Buy at Canaccord 09/16/20 CIBC Fortuna Silver Mines price target raised to C$11.50 from C$10 at CIBC 09/11/20 National Bank Fortuna Silver Mines price target raised to C$11 from C$10.50 at National Bank FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 11/13/20 Fortuna Silver Mines reports Q3 EPS 7c, consensus 10c 08/13/20 Fortuna Silver Mines reports Q2 EPS (3c), consensus 11c FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 11/13/20 Fly Intel: Pre-market Movers FSM Fortuna Silver Mines $7.59 / +0.16 (+2.15%) 01/08/21 Fortuna Silver Mines call volume above normal and directionally bullish 10/14/20 Largest borrow rate increases among liquid names 09/04/20 Fortuna Silver Mines call volume above normal and directionally bullish 07/20/20 Fortuna Silver Mines call volume above normal and directionally bullish
Recommendations	Exchange Income price target raised to C$42 from C$40 at National Bank » 11:03 01/20/21 01/20 11:03 01/20/21 11:03 EIFZF Exchange Income $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EIFZF Exchange Income $0.00 / + (+0.00%) 11/17/20 Scotiabank Exchange Income price target raised to C$38 from C$32 at Scotiabank 11/16/20 Canaccord Exchange Income price target raised to C$41 from C$36 at Canaccord 11/16/20 RBC Capital Exchange Income price target raised to C$40 from C$36 at RBC Capital 11/16/20 National Bank Exchange Income price target raised to C$40 from C$36 at National Bank

Recommendations	Whitecap Resources price target raised to C$6 from C$2.50 at Scotiabank » 11:01 01/20/21 01/20 11:01 01/20/21 11:01 SPGYF Whitecap Resources $0.00 / + (+0.00%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SPGYF Whitecap Resources $0.00 / + (+0.00%) 01/15/21 RBC Capital Whitecap Resources price target raised to C$6.50 from C$3.50 at RBC Capital 12/16/20 CIBC Whitecap Resources price target raised to C$7 from C$6 at CIBC 12/11/20 TD Securities Whitecap Resources price target raised to C$5.50 from C$3.25 at TD Securities 12/11/20 TD Securities TORC Oil and Gas downgraded to Tender from Buy at TD Securities
Recommendations	Capstone Mining price target raised to C$3.50 from C$3 at TD Securities » 11:00 01/20/21 01/20 11:00 01/20/21 11:00 CSFFF Capstone Mining $0.00 / + (+0.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CSFFF Capstone Mining $0.00 / + (+0.00%) 01/11/21 Scotiabank Capstone Mining price target raised to C$4 from C$3 at Scotiabank 01/08/21 Canaccord Capstone Mining price target raised to C$3.50 from C$3 at Canaccord 01/06/21 National Bank Capstone Mining price target raised to C$3.25 from C$2.10 at National Bank 12/17/20 BMO Capital Capstone Mining upgraded to Outperform from Market Perform at BMO Capital
Conference/Events	Danimer Scientific participates in a conference call with Jefferies » 10:57 01/20/21 01/20 10:57 01/20/21 10:57 DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events Options DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 12/29/20 Live Oak completes business combination, changes name to Danimer Scientific DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies 11:00 Today Danimer Scientific - DNMR DNMR Danimer Scientific $32.00 / +2.23 (+7.49%) 01/07/21 Three new option listings and one option delisting on January 7th
General news	Treasury Action: Treasuries are holding modest losses » 10:55 01/20/21 01/20 10:55 01/20/21 10:55 Treasury Action:… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial
Conference/Events	Danimer Scientific participates in a conference call with Jefferies » 10:52 01/20/21 01/20 10:52 01/20/21 10:52 DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) Basic Materials Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 12/29/20 Live Oak completes business combination, changes name to Danimer Scientific DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies DNMR Danimer Scientific $31.65 / +1.88 (+6.32%) 01/07/21 Three new option listings and one option delisting on January 7th

Events

Earnings calls, analyst events, roadshows and more

Today at 12:00

Software & Internet Industry Meetings
Today at 13:00

Software & Internet Industry Meetings
Today at 14:00

Food/Agribusiness Industry Meetings
Today at 14:00

Energy Transition Industry Meetings
KMI
Today at 16:30

Kinder Morgan - KMI Conference Calls
AA
Today at 17:00

Alcoa - AA Conference Calls
HWC
Today at 17:00

Hancock Whitney - HWC Conference Calls
NVEC
Today at 17:00

NVE Corp. - NVEC Conference Calls
Tomorrow at 00:00

2021 VESS Annual Winter Meeting Conferences

Virtual Meeting
AGN ...
Tomorrow at 00:00

Aesthetics Tech Virtual Summit 2021 Conferences

Virtual Summit

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Enanta price target lowered to $45 from $52 at RBC Capital

TODAY'S FREE FLY STORIES

Get Full Fly Access